Introduction
Diminished Ovarian Reserve (DOR) represents a significant challenge in reproductive medicine, characterized by a reduction in oocyte quantity and quality before the age of 40. For women undergoing in vitro fertilization and embryo transfer (IVF-ET), DOR often translates to poor clinical outcomes, including lower pregnancy rates and higher miscarriage risks. While traditional Chinese medicine, specifically acupuncture, has been suggested to improve ovarian function by regulating the neuro-endocrine system and enhancing blood flow, rigorous clinical evidence remains scarce. This study protocol outlines a large-scale, multicenter randomized controlled trial (RCT) designed to evaluate the efficacy and safety of electro-acupuncture (EA) as an adjunct to IVF-ET.
Study Design and Methodology
This trial is designed as a multicenter RCT involving 338 participants across four clinical sites in China. Women under 40 with a confirmed diagnosis of DOR are randomly assigned in a 1:1 ratio to either an electro-acupuncture treatment group or a sham control group.
The intervention consists of a 12-week "priming" phase prior to the start of the IVF cycle. The treatment group receives active EA twice weekly (24 sessions total) at specific acupoints (e.g., GV20, CV6, ST29) using low-frequency (2Hz) stimulation. The sham group receives superficial "pseudo-acupuncture" at non-meridian points with zero electrical intensity. To ensure data integrity, the trial employs a triple-blind approach where participants, outcome assessors, and statisticians remain unaware of the group assignments.
Outcome Measures and Data Collection
The primary objective is to determine if EA improves the clinical pregnancy rate per IVF-ET cycle. Beyond this primary endpoint, the study will track a comprehensive suite of secondary outcomes:
- Ovarian Reserve Markers: Serum Anti-Müllerian Hormone (AMH), Follicle-Stimulating Hormone (FSH), and Antral Follicle Count (AFC).
- IVF Performance: Number of retrieved oocytes, fertilization rates, and high-quality embryo rates.
- Biological Mechanisms: Levels of neuro-transmitters (CRH, GABA, dopamine) and oxidative stress indicators to explore how EA influences the ovarian microenvironment.
- Psychological and Quality of Life Scales: Assessment of anxiety and depression (SAS/SDS) and the Massachusetts General Hospital Acupuncture Sensation Scale (MASS) to quantify the "Deqi" sensation.
Discussion and Expected Impact
Unlike many studies that apply acupuncture concurrently with IVF stimulation, this protocol emphasizes a 12-week preparatory phase. This approach tests the hypothesis that acupuncture requires a sustained period to effectively regulate hemodynamics and the neuro-endocrine axis before the physiological stress of controlled ovarian hyperstimulation.
While the trial faces inherent challenges—such as the impossibility of blinding the practitioners and the potential for a placebo effect from the sham procedure—its large sample size and multicenter design are intended to provide high-quality evidence. If successful, this study will offer a validated integrative treatment option for women with DOR, potentially improving fertility outcomes through a non-pharmacological intervention.
Conclusion
By bridging traditional therapeutic practices with modern reproductive technology, this RCT aims to establish a standardized protocol for electro-acupuncture in the context of IVF. The results will provide critical guidance for clinicians and patients seeking to optimize ovarian function and pregnancy success in the face of diminished reserve.
Summary updated